These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32470207)

  • 1. Frequency of lupus anticoagulant in COVID-19 patients.
    Harzallah I; Debliquis A; Drénou B
    J Thromb Haemost; 2020 Oct; 18(10):2778. PubMed ID: 32470207
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to "Lupus anticoagulant is frequent in patients with Covid-19" (JTH-2020-00483).
    Tang N
    J Thromb Haemost; 2020 Aug; 18(8):2065-2066. PubMed ID: 32379935
    [No Abstract]   [Full Text] [Related]  

  • 3. Lupus Anticoagulant in Patients with Covid-19. Reply.
    Platton S; Bowles L; Pasi KJ
    N Engl J Med; 2020 Nov; 383(19):1893-1894. PubMed ID: 33095522
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.
    Gemcioglu E; Erden A; Davutoglu M; Karabuga B; Kucuksahin O
    J Clin Rheumatol; 2020 Sep; 26(6):236-237. PubMed ID: 32694351
    [No Abstract]   [Full Text] [Related]  

  • 5. Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coincidence? A case report and review of intertwining pathophysiology.
    Mantovani Cardoso E; Hundal J; Feterman D; Magaldi J
    Clin Rheumatol; 2020 Sep; 39(9):2811-2815. PubMed ID: 32720260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Lupus Anticoagulant Positivity in Patients With Coronavirus Disease 2019 (COVID-19).
    Reyes Gil M; Barouqa M; Szymanski J; Gonzalez-Lugo JD; Rahman S; Billett HH
    JAMA Netw Open; 2020 Aug; 3(8):e2017539. PubMed ID: 32785632
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiphospholipid antibodies are not elevated in patients with severe COVID-19 pneumonia and venous thromboembolism.
    Galeano-Valle F; Oblitas CM; Ferreiro-Mazón MM; Alonso-Muñoz J; Del Toro-Cervera J; di Natale M; Demelo-Rodríguez P
    Thromb Res; 2020 Aug; 192():113-115. PubMed ID: 32425261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent.
    Vollmer O; Tacquard C; Dieudonné Y; Nespola B; Sattler L; Grunebaum L; Gies V; Radosavljevic M; Kaeuffer C; Hansmann Y; Weber JC; Martin T; Arnaud L; Morel O; Guffroy A; Collange O; Mertes PM; Korganow AS; Delabranche X; Poindron V
    Autoimmun Rev; 2021 Jun; 20(6):102822. PubMed ID: 33872769
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19 and ischemic stroke: Should we systematically look for lupus anticoagulant and antiphospholipid antibodies?
    Aubignat M; Godefroy O
    Rev Neurol (Paris); 2020 Jun; 176(6):505-506. PubMed ID: 32409176
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection.
    Woo S; Kim B; Heo NH; Kim MS; Yoon YA; Choi YJ
    Clin Appl Thromb Hemost; 2022; 28():10760296221127276. PubMed ID: 36172745
    [No Abstract]   [Full Text] [Related]  

  • 11. Lupus Anticoagulant in Patients with Covid-19.
    Gooding R; Myers B; Salta S
    N Engl J Med; 2020 Nov; 383(19):1893. PubMed ID: 33095521
    [No Abstract]   [Full Text] [Related]  

  • 12. Frequency of positive antiphospholipid antibodies in pregnant women with SARS-CoV-2 infection and impact on pregnancy outcome: A single-center prospective study on 151 pregnancies.
    Gozzoli GI; Piovani E; Negri B; Mascherpa M; Orabona R; Zanardini C; Zatti S; Piantoni S; Lazzaroni MG; Tomasi C; Prefumo F; Sartori E; Franceschini F; Tincani A; Andreoli L
    Front Immunol; 2022; 13():953043. PubMed ID: 36189273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy.
    Gkrouzman E; Barbhaiya M; Erkan D; Lockshin MD
    Arthritis Rheumatol; 2021 Jan; 73(1):173-174. PubMed ID: 32901454
    [No Abstract]   [Full Text] [Related]  

  • 14. Lupus anticoagulant is frequent in patients with Covid-19.
    Harzallah I; Debliquis A; Drénou B
    J Thromb Haemost; 2020 Aug; 18(8):2064-2065. PubMed ID: 32324958
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 and antiphospholipid antibodies.
    Butt A; Erkan D; Lee AI
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101402. PubMed ID: 36494152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus anticoagulants as a prospective independent predictor in COVID-19 patients.
    Kim H; Chu D; Kim M; Cho YU; Park CJ; Bae S; Kim MJ; Chong YP; Jang S; Kim SH
    Int J Lab Hematol; 2023 Apr; 45(2):163-169. PubMed ID: 36495055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19.
    Bowles L; Platton S; Yartey N; Dave M; Lee K; Hart DP; MacDonald V; Green L; Sivapalaratnam S; Pasi KJ; MacCallum P
    N Engl J Med; 2020 Jul; 383(3):288-290. PubMed ID: 32369280
    [No Abstract]   [Full Text] [Related]  

  • 18. Lupus anticoagulant in patients with COVID-19.
    Tvito A; Ben-Chetrit E; Zimmerman FS; Asher E; Helviz Y
    Int J Lab Hematol; 2021 Feb; 43(1):e17-e18. PubMed ID: 32915472
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal immunothrombosis and lupus anticoagulant in a catastrophic COVID-19 recalling Asherson's syndrome.
    Roncati L; Corsi L; Barbolini G
    J Thromb Thrombolysis; 2021 Nov; 52(4):1043-1046. PubMed ID: 33844151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 89-Year-Old Man with COVID-19-Associated Coagulopathy Presenting with a Prolonged Partial Thromboplastin Time, Lupus Anticoagulant, and a High Titer of Factor VIII Inhibitor.
    Ghafouri S; Rettig M; Kahlon KS
    Am J Case Rep; 2020 Oct; 21():e926728. PubMed ID: 33122620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.